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SUMMARY · According to recent concepts, pleura is defined as an organ with its own biological
and functional properties. Pleura is located between two anatomically and functionally different parts
of the integral thoracopulmonary system. One is the thorax, which has an active and driving role in
the process of ventilation, and the other are the lungs, which passively follow thoracic movements.
The balance of the thoracopulmonary system can be compromised by a number of primary and even
more commonly secondary pathologic processes of the pleura that can manifest in the form of pleu-
ral effusions, air in the pleural cavity, pleural cavity obliteration, or a combination of these phenom-
ena. Variation in the histologic structure of the visceral and parietal pleura, intracavitary fluid ex-
change, and pathogenesis of pleural effusions are presented. The presence of air in the pleural cavity
indicates total disintegration of the thoracopulmonary system and substantially impedes the respira-
tory function of the lungs. Pleural obliteration or adhesions result in partial or complete pleural space
reduction and, depending on the extension and localization of adhesions, cause restriction or restric-
tion-obstruction ventilation disturbances, modify lung hemodynamics, and with time lead to pulmo-
nary hypertension and chronic pulmonary heart. The development of permanent anatomical and
functional lesions of the thoracopulmonary system can be timely prevented by an early diagnosis and
appropriate treatment of pleural changes.
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Introduction
The following systems are involved in the process of
external breathing, i.e. exchange of gases on the alveo-
capillary membrane: 1) nervous (central, peripheral, and
vegetative); 2) musculoskeletal (ribs, diaphragm, intercos-
tal musculature); 3) respiratory (upper and lower airways);
4) cardiovascular; and 5) hematopoietic (red blood cells).
Obviously, pleura as one of the important structures in the
thoracopulmonary system function is not mentioned at all.
We have been taught that pleura is a thin serous mem-
brane lining the lungs and inner wall of the thoracic cav-
ity, thus creating a space that is not visualized in physi-
ologic conditons1. However, many authors disagree with
such a definition of the pleura, stating that pleura is not
an accompanying reactive pulmonary tissue but an organ
with its own biological and functional properties2. What-
ever definition be accepted, we have to admit that pleura
is situated like a ‘buffer’ in-between two anatomically and
functionally different parts of the integral thoracopul-
monary system. One of these two is the thorax, which has
an active and driving role in the process of ventilation, and
the other are the lungs that passively increase in volume
while following the anterior-posterior and cranio-caudal
expansion of the thorax3. With its negative pressure and
mechanism of maintaining minimal fluid volume and low
protein concentration within the intrapleural cavity, pleura
compensates for the shear forces of the thorax and the
lungs. This balance of the thoracopulmonary system can
be deranged by various primary and even more commonly
secondary pathologic processes of the pleura, which can
manifest as: 1) pleural effusion; 2) air in the pleural space;
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3) obliteration of pleural cavity (adhesions); or 4) a com-
bination of these phenomena.
Histologic Structure of the Pleura
The parietal and visceral pleurae consist of two layers.
The first layer consists of squamous epithelial cells, so-
called mesothelium with basal membrane and a thin layer
of connective tissue, and overlies the other, main layer
consisting of a network of elastic and collagenous fiber4.
As there are no junctions (hemidesmosomes) between the
two layers, any irritation can readily induce scaling, i.e.
stratification and mesothelial lesion. In the parietal pleura,
a loose connective tissue sheeth, endothoracic fascia, con-
taining a network of blood and lymph vessels and nerve
fiber, is found beneath the main layer. Parietal pleura is
supplied via branches of the systemic circulation originat-
ing from the thoracic aorta (intercostal, pericardiophrenic,
phrenic and musculophrenic arteries). Venous blood is
drained to the azygos, hemiazygos and mammary veins.
Lymph drainage of the parietal pleura runs via initial
lymph capillaries and lymph orifices (stoma) located be-
tween mesothelial cells, mostly in the region of costal,
mediastinal and diaphragmatic pleura. Visceral pleura has
no endothoracic fascia but the pleural elastic fiber con-
tinue to the elastic fiber of pulmonary interstitium, where
blood and lymph capillaries are located. Visceral pleura is
mostly irrigated by branches of the pulmonary artery, and
only partly (mediastinal, interlobar and in part diaphrag-
matic surface) by branches of bronchial arteries. Venous
blood is mostly drained to pulmonary veins. As differen-
tiated from parietal pleura, visceral pleura has no lymph
orifices. Initial lymph capillaries are subpleurally located,
draining the fluid that is resorbed via visceral pleura.
Microvilli are found on the free surface of mesothelial
cells. Microvilli are minute, cilium-like processes facilitat-
ing sliding and increasing the absorptive area. They are
more abundant on visceral than on parietal pleura5,6.
Intrapleural Fluid Flow
About 20 ml of low-protein (~1 g/dl) fluid are found
in the pleural space. The fluid is distributed in a thin layer
over the pleural filaments allowing for their smooth slid-
ing motion. The fluid flow in the pleural space is well
understood and regulated by Starling’s law (Fig. 1a). The
fluid is filtered on the parietal pleura under the pressure
of +9 cm H2O, and reabsorbed on visceral pleura under
the pressure of ·10 cm H2O. The rate of filtration on the
parietal pleura and reabsorption on the visceral pleura
depends on the hydrostatic and colloid-osmotic pressure
in the capillaries of parietal and visceral pleura, and on the
intrapleural pressure. The flow of fluid through the pleu-
ral cavity can be presented by the following equation:
Fig. 1a. Intrapleural fluid flow7
Fluid flow = C x (HPc · HPp) · (CPc · COp), where C = coefficient of
filtration,
In physiologic conditions, water and small particles are
eliminated by this route. Major effusions and large par-
ticles, especially protein, are cleared from the pleural space
HPc = mean capillary hydrostatic
pressure in cm H2O,
HPp = mean pericapillary hydro-
static pressure in cm H2O (in
this case, mean intrapleural
pressure),
CPc = colloid-osmotic intracapilla-
ry plasma pressure in cm
H2O, and
COp = pericapillary colloid-osmotic
pressure in cm H2O (in this
case, colloid-osmotic pres-
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via lymph orifices (stoma) of the parietal pleura, whose
capacity is 20-fold absorption  capacity of the visceral
pleura, and which makes about 80% of total intrapleural
fluid volume (Fig. 1b). When both of these regulatory
mechanisms of intrapleural fluid flow fail due to some
pathologic process, the fluid accumulates in the pleural
cavity, with an amount of fluid exceeding 20 ml consid-
ered a pathologic event7-9.
Pathogenesis of Pleural Effusions
Pleural effusion as a primary pleural pathology, or as
a secondary manifestation of pathologic alterations of the
adjacent organs or organ systems can develop by any of
the following mechanisms: 1) hydrostatic pressure in-
crease in the parietal and visceral pleura capillaries; 2)
colloid-osmotic plasma pressure decrease; 3) increased
capillary permeability; 4) lymphostasis; 5) rupture of a
blood vessel, thoracic duct, or esophagus; and 6) combi-
nation of these mechanisms.
In patients with cardiac insufficiency or constrictive
pericarditis, pleural effusions occur due to increase in
intracapillary hydrostatic pressure, whereas in those with
liver cirrhosis, hypoalbuminemia, hydronephrosis or ne-
phrotic syndrome, pleural effusions are due to decrease in
plasma colloid-osmotic pressure. In these patients, pleura
is not pathologically altered. Effusions are usually bilat-
eral, moderate in extension, and of a transudate nature.
If left in place and treated with diuretics, they may pro-
duce a picture of pseudoexudate.
Inflammatory effusions mostly develop in association
with specific or nonspecific inflammation of the lungs and
other adjacent organs, whereas primary pleurisy is rare.
Capillary permeability is increased in the pleural inflam-
matory area, which leads to exudation and elevated concen-
tration of water binding protein, thus increasing the effu-
sion volume. Tuberculous pleurisy develops due to the pleu-
ral space invasion with caseous masses and tuberculosis
bacilli. According to the character of effusion, serofibrin-
ous and caseous pleurisy are differentiated. Serofibrinous
tuberculous effusion is clear, amber-colored, has the char-
acteristics of an exudate, and shows a tendency of sponta-
neous regression. The presence of tuberculosis bacilli is dif-
ficult to demonstrate, as they represent pleural hyperergic
reaction to the small amount of Mycobacterium (M.). tuber-
culosis in the pleural space. Caseous effusion is turbid, with
a high fibrin content, and the presence of M. tuberculosis is
easily detected. This type of effusion usually involves a large
part of the pleural and subpleural area, is associated with a
more severe clinical picture, and entails extensive posttu-
berculotic intrapleural sequels. Nonspecific pleural effusions
generally accompany lobar bacterial pneumonia, pulmonary
abscesses, inflamed bronchiectasis and cysts, and are less
frequently found in focal pneumonia, legionellosis, rickett-
sial, mycoplasmal and viral inflammation. According to the
time of development, parapneumonial effusions occurring
during pneumonia, and metapneumonial or postpneu-
monial effusions that develop secondary to the clinical pic-
ture of pneumonia are distinguished. The latter are more
extensive, more difficult to treat, and pathogenic bacteria
can rarely be detected.
Malignant pleural effusions develop in primary and
even more commonly in secondary (metastatic) pleural
tumors. These effusions are very extensive, recur soon af-
ter puncture, and can occur due to increased capillary per-
meability, blood vessel rupture, lymphostasis, or a combi-
nation of these mechanisms.
The effusions that occur due to increased capillary per-
meability and/or blood vessel rupture generally are hemor-
rhagic, have characteristics of an exudate, and malignant
cells are easily detectable. The effusions occurring due to
lymphostasis have a transudate nature, and the presence of
malignant cells is more difficult to demonstrate.
In autoimmune diseases such as rheumatoid arthritis,
systemic lupus erythematosus or Sjögren’s syndrome, mi-
nor effusions, usually bilateral and with characteristics of an
exudate, can occur. These effusions develop because of in-
creased capillary permeability and are caused by an immune
reaction on small and medium blood vessels (vasculitis).
Hemothorax and chylothorax are conditions that oc-
cur secondary to rupture of a blood vessel or thoracic duct.
Esophageal rupture may occasionally be associated with
effusion.
In addition to these effusions that are most frequently
encountered in clinical practice, effusions may also be found
in various other pathologic conditions such as uremia,
myxedema, postinfarction syndrome, pulmonary infarction,
Meigs’ syndrome, endometriosis, yellow nail syndrome,
then effusions after radiotherapy, some medication, or ex-
posure to asbestos inhalation. In the general internist popu-
lation, pleural effusions are found in some 10% of cases and
may pose a major diagnostic problem. Statistical data show
that cardiac effusions are most common, accounting for
30% · 40% of all effusions. Statistical data on noncardiac
effusions differ between America and Europe, as illustrated
in Tables 1 and 2. In Croatia, exact data on the prevalence
of effusions are still lacking10-13.
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Air in the Pleural Space (Pneumothorax)
In physiologic conditions, there is no air in the pleu-
ral cavity, and the mean intrapleural pressure at the level
of functional residual capacity (FRC) is ·5 cm H2O. If the
air occurs in the pleural cavity for any reason, the intra-
pleural pressure rises, and the function of the thoraco-
pulmonary system fails. This is best illustrated by the
curves of relaxation of the thoracopulmonary system as a
whole and of each of its structures individually (Fig. 2).
These curves show that the thorax and lungs differ both
in their shape and elastic properties. Point A on Pp + Pt
curve is the site of relaxation of the entire thoracopulmo-
nary system, representing the FRC volume, i.e. the vol-
ume at balance and rest, when the force drawing air into
the lungs equals the thoracic force drawing air out of the
lungs. Within the lungs, the pressure is zero, there is no
air flow, and the intrapleural pressure is ·5 cm H2O. Point
B on Pp curve is the site of full pulmonary relaxation. In
these conditions, the lungs have lowest volume, which is
even below the residual volume. Point C on Pt curve is the
site of complete thorax relaxation. At this point, thorax
does not exert any outward force anymore and has reached
complete relaxation, which is achieved at high volumes at
the level of 75% of vital capacity. This impairment of the
thoracopulmonary system function modifies the level of
ventilation, perfusion and ventilation/perfusion ratio, and
influences the hemodynamics; any of these segments in
the process of external respiration can be objectively re-
corded in pneumothorax. Depending on the pneumotho-
rax extension, decreased values of the vital capacity (VC),
inspiration reserve volume (IRV), expiration reserve vol-
ume (ERV), residual volume (RV), functional residual
capacity (FRC) and total capacity (TC) can be recorded
by the method of helium irrigation. If the method of pl-
ethysmography is used, however, RV, intrathoracic gas-
eous volume (IGV) and TC may be elevated. In a col-
lapsed lung, hypoventilation and shunt effect develop, thus
hypoxemia may be observed in arterial blood.
Air is being slowly resorbed from the pleural space. If
the intrapleural air be left to spontaneous resorption, then,
according to Magyar and Miskovitsh17, 37 days would be
required for resorption of the air of completely collapsed
lungs, or 29 days for 8-cm, 18 days for 5-cm and 14 days
for 2- to 3-cm air mantle. Air resorption from the pleu-
ral space occurs due to the gradient of intrapleural air
pressure and total gas pressure in the venous segment of
the capillary. In other words, total venous gas pressure is
lower than total gas pressure in the alveolus, artery and
pleural space. This difference occurs at the moment of
arterial blood venozation, i.e. when PO2 decrease exceeds
by many millimeters of mercury (from 90 to 40 mm Hg)








Table 2. Prevalence of pleural effusions in the USA14
Etiology n % of % of
total noncardiac
Cardiac 500,000 37.50
Pneumonia 400,000 30.00 48.00
Neoplasms 200,000 15.00 24.00
Pulmonary embolism 150,000 11.00 18.00
Liver cirrhosis 50,000 4.00 6.00
Abdominal pathology 25,000 2.00 3.00
Autoimmune diseases 6,000 0.50 0.70
Tuberculosis 2,500 0.20 0.30
Asbestos effusion 2,000 0.15 0.25
Fig. 2. Thoracopulmonary system relaxation curves
VC (%) TC (%)
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the PCO2 increase (from 40 to 46 mm Hg). The reason
for such a pattern of respiratory gases lies in the different
shape of dissociation curves for oxygen and carbon diox-
ide (Fig. 3).
Air resorption from the pleural space is limited by
nitrogen, because it acts as an inert gas, i.e. is character-
ized by poor water solubility and poor chemical binding.
In contrast, air resorption from the pleural space is accel-
erated by the use of oxygen to increase PaO2, which is
frequently low in patients with pneumothorax14-19.
Intrapleural Obliteration (Adhesions)
Adhesions are permanent pleural lesions that occur
secondary to specific or nonspecific pleurisy, empyema,
trauma, treated pneumothorax, asbestos exposure, or in
association with some systemic diseases. Histologically,
adhesions consist of connective tissue with some collag-
enous fiber, and are well vascularized via branches of sys-
temic circulation. This should be borne in mind, as these
vessels may sustain rupture and cause abundant hemor-
rhage in pneumothorax. Depending on the size and ex-
tension of intrapleural adhesions, they lead to anatomic
modifications of the thorax and lungs, whereas in the late
stage of disease the respiratory function of the lungs may
be impeded.The process of parietal pleura fibrozation may
involve endothoracic fascia and intercostal muscle, lead-
ing to the narrowing of intercostal spaces and weakening
of the chest movements. Visceral pleura fibrozation in-
volves subpleural region and leads to morphologic changes
of the interstitium, peripheral vasculature and bronchi.
Intrapleural pressure disappears with the formation of
adhesions. The elastic forces of the lungs are directly con-
nected to the elastic shear forces of the thorax, thus be-
ing mostly abolished, which results in small, low-volume
thorax excursions.
Impairment of the respiratory function of the lungs
depends on the extension and localization of adhesions.
Apical adhesions do not induce any major impairment of
the pulmonary function. The adhesions localized in the
region of diaphragm and laterobasal parts of the thorax
cause more severe events in the respiratory function of the
lungs, because the main inspiration muscle, the dia-
phragm, has thus been rendered nonfunctional. Such
unilateral total diaphragmatic dysfunction causes more
severe functional impairments than partial pneumotho-
rax, lobectomy or thoracoplasty. On spirometry, it is mani-
fested by a decrease in IRV, then in VC and TC, and these
values are read-off as a restriction impairment of pulmo-
nary ventilation. A combination of apicomediastinal and
costodiaphragmatic adhesions with cranial hilum retrac-
tion, and with restrictive disturbances also leads to ob-
struction impairments of ventilation. In this case, the
uniform traction force relations in the lungs are changed,
with a prevalence of vertical stretching of pulmonary pa-
renchyma, which in turn leads to morphological changes
of the bronchi and vasculature. Obliteration of the entire
pleural space is described by the clinical and radiologic
term of fibrothorax. It is a condition where pleural space
does not exist anymore but has been replaced by connec-
tive tissue, and the process of fibrozation has involved the
entire thorax, leading to its malformation and reducing the
driving force of the thorax to the minimum. On the other
hand, the process of fibrozation is transferred from vis-
ceral pleura to pulmonary parenchyma, where rearrange-
ment of the pulmonary structures occurs, including an-
Fig. 3. Air resorption from pleural space18
Air resorption from the pleural space (Gauer)
Alv. art. ven Pleural
space
PH2O
47 47 47 470
PCO2
38 40 46 46.1
PO2
100 90 40 40.9
PN2
562 564 564 613
ΣP 747 741 697 747
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gulation, dilatation and deformities of the bronchi with
stasis of discharge, destruction of alveolar septa, and de-
velopment of paraseptal emphysema. The changes de-
scribed compromise ventilation as well as pulmonary cir-
Conclusion
The concepts presented lead to the following conclu-
sions: pleura has a very important role in the function of
thoracopulmonary system; pathologic processes in the
lungs and other organ systems are very early recorded and
signalled by the pleura; unless appropriate diagnosis and
treatment of pleural processes are performed on time,
permanent anatomical and functional lesions of the
thoracopulmonary system can occur, mostly manifesting
as impaired respiratory function of the lungs.
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culation, which leads to the development of pulmonary
hypertension and chronic pulmonary heart (Fig. 4).
Although adhesions generally present a definite con-
dition, clinically the possibility of tuberculosis reactivation,
secondary infection with pleurocutaneous fistula, choles-
terol pleurisy, and malignant diseases should be consid-
ered20-23.
Pleural Plaques
The individuals inhaling air contaminated with asbes-
tos dust can sustain pleural and pulmonary lesions, which
manifest as pleural plaques, asbestos pleurisy, costodia-
phragmatic adhesions, pulmonary fibrosis (asbestosis),
and malignant mesothelioma.
Pleural plaques are most common of these morpho-
logic changes, and can serve as a marker of the level of
atmosphere contamination with asbestos. Large-scale
radiologic studies have shown the presence of pleural
plaques in 0.02% to 3% of the general population, and in
up to 30% of individuals at occupational asbestos expo-
sure. Pleural plaques appear as small islets of smooth sur-
face, sharply demarcated, consisting mostly of hyalin, and
are usually located on parietal pleura (diaphragmatic, cos-
tal and mediastinal). Pleural plaques do not cause any
major impairments in the respiratory function of the
lungs. The persons found to have pleural plaques belong
to a risk group who require systematic follow-up, because
Fig. 4. Pathogenesis of the lung respiratory function impairment in fibrothorax
Pulmonary circulation impairment
• reduced subpleural space perfusion, mechanical and reflex (Euler-
Liljistrand mechanism)
• ‘aortalization’ of microcirculation via communication capillaries from
parietal pleura
Ventilation impairment
• respiratory mechanics impairment
• restrictive ventilation impairment










pleural mesothelioma or bronchial carcinoma may develop
after a long latency period of 30-40 years24-27.
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Saæetak
PATOFIZIOLOGIJA PLEURALNOG PROSTORA
I. Grbac, V. StanËiÊ, M. BaËiÊ-Grbac i D. Jurman
Pleura se prema novijim shvaÊanjima definira kao organ koji ima svoja biolo¹ka i funkcijska svojstva. Pleura je smje¹tena
izmeðu dvaju anatomski i funkcijski razliËitih dijelova jedinstvenog torakopulmonalnog sustava. Jedan je toraks koji ima
djelatnu i pokretaËku ulogu u procesu ventilacije, a drugi su pluÊa koja pasivno prate pokrete toraksa. Ravnoteæu
torakopulmonalnog sustava mogu naru¹iti razliËiti primarni, ali Ëe¹Êe sekundarni patolo¹ki procesi pleure, koji se mogu oËitovati
u obliku izljeva u pleuralnom prostoru, zraka u pleuralnom prostoru, obliteracijom pleuralnog prostora ili kombinacijom
spomenutih pojava. Prikazane su raznolikosti u histolo¹koj graði visceralne i parijetalne pleure, zatim izmjena tekuÊine u
pleuralnom prostoru, te patogeneza pleuralnih izljeva. Zrak u pleuralnom prostoru oznaËava potpun raspad torakopulmonalnog
sustava i bitno naru¹ava respiracijsku funkciju pluÊa. Obliteracije ili priraslice djelomice ili potpuno smanjuju pleuralni prostor,
a ovisno o pro¹irenosti i lokalizaciji priraslica uzrokuju restrikcijske ili restrikcijsko-opstrukcijske smetnje ventilacije, mijenjaju
pluÊnu hemodinamiku i s vremenom dovode do pluÊne hipertenzije i kroniËnog pluÊnog srca. Ranom dijagnostikom, a potom
i lijeËenjem pleuralnih promjena moæe se na vrijeme zaustaviti nastanak trajnih anatomskih i funkcijskih promjena
torakopulmonalnog sustava.
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